InvestorsHub Logo

BTH

11/09/10 12:57 PM

#3226 RE: DonShimoda #3224

doesn't matter one iota



Yeah, you're right. The EORTC data doesn't.

But you should be really disturbed if many of the patients in the trial have had AIM and/or MAID chemo regimens going into the SUCCEED trial (considering those regimens both had roughly a 26 week median PFS).